ATHA

Athira Pharma, Inc.CIK 1620463 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for ATHA PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for ATHA

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Renninger Robert	VP of Finance	19	$0	$4.5K	2026-01-02
Worthington Mark	General Counsel and CCO	31	$0	$35.8K	2026-01-02
CHURCH KEVIN	Vice President of Discovery	50	$0	$35.8K	2026-01-02
San Martin Javier	CHIEF MEDICAL OFFICER	15	$0	$20.5K	2026-01-02
Litton Mark James	President and CEO	41	$0	$91.5K	2026-01-02
PERCEPTIVE ADVISORS LLC	Director, 10% Owner	9	$0	$0	2025-12-23
Kosacz Barbara	Director	5	$0	$0	2025-05-30
Romano Kelly A	Director	9	$303.8K	$0	2025-05-30
Panzara Michael A.	Director	5	$0	$0	2025-05-30
PICKERING GRANT	Director	7	$60.4K	$0	2025-05-30
JOHNSON JAMES A	Director	6	$12.0K	$0	2025-05-30
FLUKE JOHN M JR	Director	17	$0	$0	2025-05-30
EDELMAN JOSEPH	Director, 10% Owner	14	$30.56M	$0	2025-05-30
Lenington Rachel	Chief Operating Officer	12	$0	$26.8K	2024-09-05
Gengos Andrew	See Below	19	$243.1K	$7.8K	2024-09-05
MOEBIUS HANS	Chief Medical Officer	19	$45.3K	$0	2024-01-04
MILESON GLENNA	Chief Financial Officer	16	$142.5K	$7.0K	2023-01-19
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD	Director, 10% Owner	5	$18.00M	$0	2022-05-20
Yamada Tadataka	Director	1	$0	$0	2021-05-28
KAWAS LEEN	President & CEO	1	$0	$0	2021-02-18
RTW INVESTMENTS, LP	10% Owner	3	$12.75M	$0	2020-09-18

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Worthington Mark	General Counsel and CCO	S Sale	2026-01-02	2026-01-05	876	$6.88	$6.0K	13,978	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	S Sale	2026-01-02	2026-01-05	876	$6.88	$6.0K	20,681	SEC↗
Renninger Robert	Chief Financial Officer	S Sale	2026-01-02	2026-01-05	297	$6.88	$2.0K	12,857	SEC↗
Litton Mark James	President and CEO	S Sale	2026-01-02	2026-01-05	2,586	$6.88	$17.8K	40,828	SEC↗
San Martin Javier	CHIEF MEDICAL OFFICER	S Sale	2026-01-02	2026-01-05	1,644	$6.88	$11.3K	10,189	SEC↗
Worthington Mark	General Counsel and CCO	M Exercise deriv	2025-12-31	2026-01-05	3,667	—	$0	0	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	M Exercise deriv	2025-12-31	2026-01-05	3,667	—	$0	0	SEC↗
Renninger Robert	Chief Financial Officer	M Exercise deriv	2025-12-31	2026-01-05	1,236	—	$0	0	SEC↗
Litton Mark James	President and CEO	M Exercise deriv	2025-12-31	2026-01-05	10,834	—	$0	0	SEC↗
San Martin Javier	CHIEF MEDICAL OFFICER	M Exercise deriv	2025-12-31	2026-01-05	4,667	—	$0	0	SEC↗
Worthington Mark	General Counsel and CCO	M Exercise	2025-12-31	2026-01-05	3,667	—	$0	14,854	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	M Exercise	2025-12-31	2026-01-05	3,667	—	$0	21,557	SEC↗
Renninger Robert	Chief Financial Officer	M Exercise	2025-12-31	2026-01-05	1,236	—	$0	13,154	SEC↗
Litton Mark James	President and CEO	M Exercise	2025-12-31	2026-01-05	10,834	—	$0	43,414	SEC↗
San Martin Javier	CHIEF MEDICAL OFFICER	M Exercise	2025-12-31	2026-01-05	4,667	—	$0	11,833	SEC↗
Worthington Mark	General Counsel and CCO	A Award deriv	2025-12-24	2025-12-29	34,358	—	$0	34,358	SEC↗
San Martin Javier	CHIEF MEDICAL OFFICER	A Award deriv	2025-12-24	2025-12-29	44,508	—	$0	44,508	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	A Award deriv	2025-12-24	2025-12-29	35,138	—	$0	35,138	SEC↗
Litton Mark James	President and CEO	A Award deriv	2025-12-24	2025-12-29	133,526	—	$0	133,526	SEC↗
Renninger Robert	Chief Financial Officer	A Award deriv	2025-12-24	2025-12-29	34,358	—	$0	34,358	SEC↗
PERCEPTIVE ADVISORS LLC	Director, 10% Owner	A Award deriv	2025-12-23	2025-12-23	1,279,526	$6.35	$8.12M	1,279,526	SEC↗
PERCEPTIVE ADVISORS LLC	Director, 10% Owner	A Award deriv	2025-12-23	2025-12-23	1,372,935	$6.35	$8.72M	1,372,935	SEC↗
PERCEPTIVE ADVISORS LLC	Director, 10% Owner	A Award deriv	2025-12-23	2025-12-23	3,838,583	$6.35	$24.38M	3,838,583	SEC↗
PERCEPTIVE ADVISORS LLC	Director, 10% Owner	A Award deriv	2025-12-23	2025-12-23	3,543,307	$6.35	$22.50M	3,543,307	SEC↗
PERCEPTIVE ADVISORS LLC	Director, 10% Owner	A Award deriv	2025-12-23	2025-12-23	457,645	$6.35	$2.91M	457,645	SEC↗
PERCEPTIVE ADVISORS LLC	Director, 10% Owner	A Award deriv	2025-12-23	2025-12-23	1,181,101	$6.35	$7.50M	1,181,101	SEC↗
PERCEPTIVE ADVISORS LLC	Director, 10% Owner	A Award deriv	2025-12-23	2025-12-23	5,502,402	—	$0	5,502,402	SEC↗
PERCEPTIVE ADVISORS LLC	Director, 10% Owner	A Award	2025-12-23	2025-12-23	329,756	$6.35	$2.09M	329,756	SEC↗
PERCEPTIVE ADVISORS LLC	Director, 10% Owner	A Award	2025-12-23	2025-12-23	989,270	$6.35	$6.28M	1,529,566	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	A Award	2025-11-18	2026-01-05	1,000	$2.31	$2.3K	17,890	SEC↗
Renninger Robert	Chief Financial Officer	A Award	2025-11-18	2026-01-05	1,000	$2.31	$2.3K	11,918	SEC↗
Renninger Robert	SVP, Finance and Accounting	S Sale	2025-07-01	2025-07-02	2,897	$0.29	$840	109,186	SEC↗
Worthington Mark	General Counsel and CCO	S Sale	2025-07-01	2025-07-02	8,526	$0.29	$2.5K	111,875	SEC↗
San Martin Javier	CHIEF MEDICAL OFFICER	S Sale	2025-07-01	2025-07-02	10,842	$0.29	$3.1K	71,665	SEC↗
Litton Mark James	President and CEO	S Sale	2025-07-01	2025-07-02	25,123	$0.29	$7.3K	325,802	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	S Sale	2025-07-01	2025-07-02	8,526	$0.29	$2.5K	168,901	SEC↗
Renninger Robert	SVP, Finance and Accounting	M Exercise deriv	2025-06-30	2025-07-02	12,359	—	$0	12,359	SEC↗
Worthington Mark	General Counsel and CCO	M Exercise deriv	2025-06-30	2025-07-02	36,666	—	$0	36,667	SEC↗
San Martin Javier	CHIEF MEDICAL OFFICER	M Exercise deriv	2025-06-30	2025-07-02	46,666	—	$0	46,667	SEC↗
Litton Mark James	President and CEO	M Exercise deriv	2025-06-30	2025-07-02	108,334	—	$0	108,333	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	M Exercise deriv	2025-06-30	2025-07-02	36,666	—	$0	36,667	SEC↗
Renninger Robert	SVP, Finance and Accounting	M Exercise	2025-06-30	2025-07-02	12,359	—	$0	112,083	SEC↗
Worthington Mark	General Counsel and CCO	M Exercise	2025-06-30	2025-07-02	36,666	—	$0	120,401	SEC↗
San Martin Javier	CHIEF MEDICAL OFFICER	M Exercise	2025-06-30	2025-07-02	46,666	—	$0	82,507	SEC↗
Litton Mark James	President and CEO	M Exercise	2025-06-30	2025-07-02	108,334	—	$0	350,925	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	M Exercise	2025-06-30	2025-07-02	36,666	—	$0	177,427	SEC↗
PICKERING GRANT	Director	A Award deriv	2025-05-30	2025-06-03	20,900	—	$0	20,900	SEC↗
Kosacz Barbara	Director	A Award deriv	2025-05-30	2025-06-03	20,900	—	$0	20,900	SEC↗
JOHNSON JAMES A	Director	A Award deriv	2025-05-30	2025-06-03	20,900	—	$0	20,900	SEC↗
EDELMAN JOSEPH	Director	A Award deriv	2025-05-30	2025-06-03	20,900	—	$0	20,900	SEC↗
Romano Kelly A	Director	A Award deriv	2025-05-30	2025-06-03	20,900	—	$0	20,900	SEC↗
Panzara Michael A.	Director	A Award deriv	2025-05-30	2025-06-03	20,900	—	$0	20,900	SEC↗
FLUKE JOHN M JR	Director	A Award deriv	2025-05-30	2025-06-03	20,900	—	$0	20,900	SEC↗
Renninger Robert	SVP, Finance and Accounting	A Award	2025-05-19	2025-07-02	10,000	$0.23	$2.3K	99,724	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	A Award	2025-05-19	2025-07-02	10,000	$0.23	$2.3K	140,761	SEC↗
Worthington Mark	General Counsel and CCO	A Award deriv	2025-03-03	2025-03-04	85,895	—	$0	85,895	SEC↗
Worthington Mark	General Counsel and CCO	A Award deriv	2025-03-03	2025-03-04	57,263	—	$0	57,263	SEC↗
San Martin Javier	CHIEF MEDICAL OFFICER	A Award deriv	2025-03-03	2025-03-04	74,180	—	$0	74,180	SEC↗
San Martin Javier	CHIEF MEDICAL OFFICER	A Award deriv	2025-03-03	2025-03-04	111,270	—	$0	111,270	SEC↗
Litton Mark James	President and CEO	A Award deriv	2025-03-03	2025-03-04	333,815	—	$0	333,815	SEC↗
Litton Mark James	President and CEO	A Award deriv	2025-03-03	2025-03-04	222,543	—	$0	222,543	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	A Award deriv	2025-03-03	2025-03-04	58,563	—	$0	58,563	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	A Award deriv	2025-03-03	2025-03-04	87,845	—	$0	87,845	SEC↗
Renninger Robert	SVP, Finance and Accounting	A Award deriv	2025-03-03	2025-03-04	58,500	—	$0	58,500	SEC↗
Renninger Robert	SVP, Finance and Accounting	A Award deriv	2025-03-03	2025-03-04	73,350	—	$0	73,350	SEC↗
Renninger Robert	SVP, Finance and Accounting	A Award deriv	2025-03-03	2025-03-04	39,000	—	$0	39,000	SEC↗
Renninger Robert	SVP, Finance and Accounting	A Award deriv	2025-03-03	2025-03-12	73,350	—	$0	73,350	SEC↗
Worthington Mark	General Counsel and CCO	S Sale	2025-01-02	2025-01-03	8,510	$0.56	$4.8K	83,735	SEC↗
Renninger Robert	VP of Finance	S Sale	2025-01-02	2025-01-03	2,881	$0.56	$1.6K	89,724	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	S Sale	2025-01-02	2025-01-03	8,510	$0.56	$4.8K	130,761	SEC↗
Litton Mark James	President and CEO	S Sale	2025-01-02	2025-01-03	25,107	$0.56	$14.1K	242,591	SEC↗
San Martin Javier	CHIEF MEDICAL OFFICER	S Sale	2025-01-02	2025-01-03	10,826	$0.56	$6.1K	35,841	SEC↗
Worthington Mark	General Counsel and CCO	M Exercise deriv	2024-12-31	2025-01-03	36,667	—	$0	73,333	SEC↗
Renninger Robert	VP of Finance	M Exercise deriv	2024-12-31	2025-01-03	12,359	—	$0	24,718	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	M Exercise deriv	2024-12-31	2025-01-03	36,667	—	$0	73,333	SEC↗
Litton Mark James	President and CEO	M Exercise deriv	2024-12-31	2025-01-03	108,333	—	$0	216,667	SEC↗
San Martin Javier	CHIEF MEDICAL OFFICER	M Exercise deriv	2024-12-31	2025-01-03	46,667	—	$0	93,333	SEC↗
Worthington Mark	General Counsel and CCO	M Exercise	2024-12-31	2025-01-03	36,667	—	$0	92,245	SEC↗
Renninger Robert	VP of Finance	M Exercise	2024-12-31	2025-01-03	12,359	—	$0	92,605	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	M Exercise	2024-12-31	2025-01-03	36,667	—	$0	139,271	SEC↗
Litton Mark James	President and CEO	M Exercise	2024-12-31	2025-01-03	108,333	—	$0	267,698	SEC↗
San Martin Javier	CHIEF MEDICAL OFFICER	M Exercise	2024-12-31	2025-01-03	46,667	—	$0	46,667	SEC↗
Worthington Mark	General Counsel and CCO	A Award	2024-11-18	2025-01-03	3,651	$0.55	$2.0K	55,578	SEC↗
Renninger Robert	VP of Finance	A Award	2024-11-18	2025-01-03	3,651	$0.55	$2.0K	80,246	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	A Award	2024-11-18	2025-01-03	9,920	$0.55	$5.5K	102,604	SEC↗
Litton Mark James	President and CEO	A Award deriv	2024-10-03	2024-10-03	325,000	—	$0	325,000	SEC↗
Litton Mark James	President and CEO	A Award deriv	2024-10-03	2024-10-03	325,000	—	$0	325,000	SEC↗
Litton Mark James	President and CEO	A Award deriv	2024-10-03	2024-10-03	325,000	—	$0	325,000	SEC↗
Worthington Mark	General Counsel and CCO	A Award deriv	2024-10-01	2024-10-03	110,000	—	$0	110,000	SEC↗
Worthington Mark	General Counsel and CCO	A Award deriv	2024-10-01	2024-10-03	110,000	—	$0	110,000	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	A Award deriv	2024-10-01	2024-10-03	110,000	—	$0	110,000	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	A Award deriv	2024-10-01	2024-10-03	110,000	—	$0	110,000	SEC↗
San Martin Javier	CHIEF MEDICAL OFFICER	A Award deriv	2024-10-01	2024-10-03	140,000	—	$0	140,000	SEC↗
San Martin Javier	CHIEF MEDICAL OFFICER	A Award deriv	2024-10-01	2024-10-03	140,000	—	$0	140,000	SEC↗
Renninger Robert	VP of Finance	A Award deriv	2024-10-01	2024-10-03	37,077	—	$0	37,077	SEC↗
Renninger Robert	VP of Finance	A Award deriv	2024-10-01	2024-10-03	37,077	—	$0	37,077	SEC↗
Litton Mark James	President and CEO	S Sale	2024-09-05	2024-09-05	5,032	$0.57	$2.9K	159,365	SEC↗
Worthington Mark	GENERAL COUNSEL	S Sale	2024-09-05	2024-09-05	2,525	$0.57	$1.4K	51,927	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	S Sale	2024-09-05	2024-09-05	2,525	$0.57	$1.4K	92,684	SEC↗
Lenington Rachel	COO and CDO	S Sale	2024-09-05	2024-09-05	2,525	$0.57	$1.4K	20,870	SEC↗
Gengos Andrew	CFO and Chief Business Offic	S Sale	2024-09-05	2024-09-05	1,272	$0.57	$725	97,532	SEC↗
Litton Mark James	President and CEO	A Award	2024-09-03	2024-09-05	20,000	—	$0	164,397	SEC↗
Worthington Mark	GENERAL COUNSEL	A Award	2024-09-03	2024-09-05	10,000	—	$0	54,452	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	A Award	2024-09-03	2024-09-05	10,000	—	$0	95,209	SEC↗
Lenington Rachel	COO and CDO	A Award	2024-09-03	2024-09-05	10,000	—	$0	23,395	SEC↗
Gengos Andrew	CFO and Chief Business Offic	A Award	2024-09-03	2024-09-05	5,000	—	$0	98,804	SEC↗
Romano Kelly A	Director	P Buy	2024-06-24	2024-06-25	27,400	$2.42	$66.3K	80,715	SEC↗
Romano Kelly A	Director	P Buy	2024-06-21	2024-06-25	15,000	$2.26	$33.9K	53,315	SEC↗
FLUKE JOHN M JR	Director	A Award deriv	2024-05-24	2024-05-24	20,900	—	$0	20,900	SEC↗
PICKERING GRANT	Director	A Award deriv	2024-05-24	2024-05-24	20,900	—	$0	20,900	SEC↗
Panzara Michael A.	Director	A Award deriv	2024-05-24	2024-05-24	20,900	—	$0	20,900	SEC↗
Kosacz Barbara	Director	A Award deriv	2024-05-24	2024-05-24	20,900	—	$0	20,900	SEC↗
JOHNSON JAMES A	Director	A Award deriv	2024-05-24	2024-05-24	20,900	—	$0	20,900	SEC↗
EDELMAN JOSEPH	Director	A Award deriv	2024-05-24	2024-05-24	20,900	—	$0	20,900	SEC↗
Romano Kelly A	Director	A Award deriv	2024-05-24	2024-05-24	20,900	—	$0	20,900	SEC↗
Worthington Mark	GENERAL COUNSEL	A Award	2024-05-20	2024-09-05	10,000	$1.34	$13.4K	44,452	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	A Award	2024-05-20	2024-09-05	4,953	$1.34	$6.6K	85,209	SEC↗
Gengos Andrew	CFO and Chief Business Offic	A Award	2024-05-20	2024-09-05	10,000	$1.34	$13.4K	93,804	SEC↗
San Martin Javier	CHIEF MEDICAL OFFICER	A Award deriv	2024-04-15	2024-04-16	400,000	—	$0	400,000	SEC↗
Litton Mark James	CEO	A Award deriv	2024-02-15	2024-02-16	650,000	—	$0	650,000	SEC↗
Lenington Rachel	COO AND CDO	A Award deriv	2024-02-14	2024-02-16	300,000	—	$0	300,000	SEC↗
Gengos Andrew	CFO AND CHIEF BUSINESS OFFIC	A Award deriv	2024-02-14	2024-02-16	280,000	—	$0	280,000	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	A Award deriv	2024-02-14	2024-02-16	220,000	—	$0	220,000	SEC↗
Worthington Mark	GENERAL COUNSEL	A Award deriv	2024-02-14	2024-02-16	220,000	—	$0	220,000	SEC↗
Lenington Rachel	Chief Operating Officer	S Sale	2024-01-05	2024-01-08	2,412	$2.91	$7.0K	13,395	SEC↗
Worthington Mark	General Counsel	S Sale	2024-01-05	2024-01-08	2,412	$2.91	$7.0K	34,452	SEC↗
Litton Mark James	Chief Executive Officer	S Sale	2024-01-05	2024-01-08	4,820	$2.91	$14.0K	144,397	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	S Sale	2024-01-05	2024-02-16	2,412	$2.91	$7.0K	80,256	SEC↗
Gengos Andrew	CFO AND CHIEF BUSINESS OFFIC	S Sale	2024-01-05	2024-02-16	1,208	$2.91	$3.5K	83,804	SEC↗
Worthington Mark	GENERAL COUNSEL	S Sale	2024-01-05	2024-02-16	2,412	$2.91	$7.0K	34,452	SEC↗
Litton Mark James	CEO	S Sale	2024-01-05	2024-02-16	4,820	$2.91	$14.0K	144,397	SEC↗
Lenington Rachel	COO AND CDO	S Sale	2024-01-05	2024-02-16	2,412	$2.91	$7.0K	13,395	SEC↗
Lenington Rachel	Chief Operating Officer	A Award	2024-01-04	2024-01-08	10,000	—	$0	15,807	SEC↗
Worthington Mark	General Counsel	A Award	2024-01-04	2024-01-08	10,000	—	$0	36,864	SEC↗
Litton Mark James	Chief Executive Officer	A Award	2024-01-04	2024-01-08	20,000	—	$0	149,217	SEC↗
MOEBIUS HANS	Chief Medical Officer	A Award	2024-01-04	2024-01-08	10,000	—	$0	91,482	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	A Award	2024-01-04	2024-02-16	10,000	—	$0	82,668	SEC↗
Gengos Andrew	CFO AND CHIEF BUSINESS OFFIC	A Award	2024-01-04	2024-02-16	5,000	—	$0	85,012	SEC↗
Worthington Mark	GENERAL COUNSEL	A Award	2024-01-04	2024-02-16	10,000	—	$0	36,864	SEC↗
Litton Mark James	CEO	A Award	2024-01-04	2024-02-16	20,000	—	$0	149,217	SEC↗
Lenington Rachel	COO AND CDO	A Award	2024-01-04	2024-02-16	10,000	—	$0	15,807	SEC↗
EDELMAN JOSEPH	Director, 10% Owner	P Buy	2023-12-29	2023-12-29	163,954	$2.38	$390.2K	5,402,964	SEC↗
EDELMAN JOSEPH	Director, 10% Owner	P Buy	2023-12-28	2023-12-29	409,598	$2.44	$999.4K	5,239,010	SEC↗
EDELMAN JOSEPH	Director, 10% Owner	P Buy	2023-12-27	2023-12-29	32,134	$2.28	$73.3K	4,829,412	SEC↗
CHURCH KEVIN	Chief Scientific Officer	A Award	2023-11-20	2024-01-08	3,397	$1.34	$4.6K	72,668	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	A Award	2023-11-20	2024-02-16	3,397	$1.34	$4.6K	72,668	SEC↗
Gengos Andrew	See Below	P Buy	2023-06-07	2023-06-09	2,859	$3.40	$9.7K	68,293	SEC↗
Gengos Andrew	See Below	P Buy	2023-06-07	2023-06-09	422	$3.36	$1.4K	65,434	SEC↗
Gengos Andrew	See Below	P Buy	2023-06-07	2023-06-09	11,719	$3.44	$40.3K	80,012	SEC↗
Gengos Andrew	See Below	P Buy	2023-06-05	2023-06-06	15,000	$3.00	$45.0K	35,012	SEC↗
Gengos Andrew	See Below	P Buy	2023-06-05	2023-06-06	10,000	$3.00	$30.0K	55,012	SEC↗
Gengos Andrew	See Below	P Buy	2023-06-05	2023-06-06	10,000	$3.00	$30.0K	45,012	SEC↗
Gengos Andrew	See Below	P Buy	2023-06-05	2023-06-06	10,000	$3.02	$30.2K	65,012	SEC↗
MOEBIUS HANS	Chief Medical Officer	M Exercise deriv	2023-06-02	2023-06-06	7,882	—	$0	0	SEC↗
MOEBIUS HANS	Chief Medical Officer	M Exercise	2023-06-02	2023-06-06	7,882	$1.35	$10.6K	81,482	SEC↗
Gengos Andrew	See Below	P Buy	2023-06-02	2023-06-06	3,418	$2.95	$10.1K	20,012	SEC↗
Gengos Andrew	See Below	P Buy	2023-06-02	2023-06-06	6,582	$2.86	$18.8K	16,594	SEC↗
Gengos Andrew	See Below	P Buy	2023-06-02	2023-06-06	10,012	$2.75	$27.5K	10,012	SEC↗
PICKERING GRANT	Director	A Award deriv	2023-05-19	2023-05-22	20,900	—	$0	20,900	SEC↗
FLUKE JOHN M JR	Director	A Award deriv	2023-05-19	2023-05-22	20,900	—	$0	20,900	SEC↗
Panzara Michael A.	Director	A Award deriv	2023-05-19	2023-05-22	20,900	—	$0	20,900	SEC↗
EDELMAN JOSEPH	Director	A Award deriv	2023-05-19	2023-05-22	20,900	—	$0	20,900	SEC↗
Kosacz Barbara	Director	A Award deriv	2023-05-19	2023-05-22	20,900	—	$0	20,900	SEC↗
JOHNSON JAMES A	Director	A Award deriv	2023-05-19	2023-05-22	20,900	—	$0	20,900	SEC↗
Romano Kelly A	Director	A Award deriv	2023-05-19	2023-05-22	20,900	—	$0	20,900	SEC↗
CHURCH KEVIN	Chief Scientific Officer	A Award	2023-05-18	2024-01-08	809	$2.41	$1.9K	69,271	SEC↗
Worthington Mark	General Counsel	A Award	2023-05-18	2024-01-08	7,767	$2.41	$18.7K	26,864	SEC↗
CHURCH KEVIN	CHIEF SCIENTIFIC OFFICER	A Award	2023-05-18	2024-02-16	809	$2.41	$1.9K	69,271	SEC↗
Worthington Mark	GENERAL COUNSEL	A Award	2023-05-18	2024-02-16	7,767	$2.41	$18.7K	26,864	SEC↗
Gengos Andrew	See Below	A Award deriv	2023-05-18	2023-05-22	400,000	—	$0	400,000	SEC↗
MOEBIUS HANS	Chief Medical Officer	A Award	2023-05-18	2023-06-06	7,764	$2.41	$18.7K	73,600	SEC↗
PICKERING GRANT	Director	P Buy	2023-03-30	2023-03-31	15,000	$2.47	$37.0K	25,783	SEC↗
JOHNSON JAMES A	Director	P Buy	2023-03-29	2023-03-30	5,000	$2.40	$12.0K	5,000	SEC↗
PICKERING GRANT	Director	P Buy	2023-03-29	2023-03-31	10,000	$2.33	$23.3K	10,783	SEC↗
CHURCH KEVIN	Chief Scientific Officer	M Exercise deriv	2023-03-24	2023-03-27	6,410	—	$0	0	SEC↗
CHURCH KEVIN	Chief Scientific Officer	M Exercise	2023-03-24	2023-03-27	6,410	$1.35	$8.7K	68,462	SEC↗
Litton Mark James	Chief Executive Officer	A Award deriv	2023-01-27	2023-01-31	425,000	—	$0	425,000	SEC↗
CHURCH KEVIN	Executive VP, Research	A Award deriv	2023-01-19	2023-01-23	150,000	—	$0	150,000	SEC↗
Lenington Rachel	Chief Operating Officer	A Award deriv	2023-01-19	2023-01-23	200,000	—	$0	200,000	SEC↗
MILESON GLENNA	Chief Financial Officer	A Award deriv	2023-01-19	2023-01-23	150,000	—	$0	150,000	SEC↗
MOEBIUS HANS	Chief Medical Officer	A Award deriv	2023-01-19	2023-01-23	200,000	—	$0	200,000	SEC↗
Worthington Mark	General Counsel	A Award deriv	2023-01-19	2023-01-23	150,000	—	$0	150,000	SEC↗
CHURCH KEVIN	Chief Scientific Officer	S Sale	2023-01-05	2024-01-08	2,412	$2.91	$7.0K	80,256	SEC↗
Gengos Andrew	See Below	S Sale	2023-01-05	2024-01-08	1,208	$2.91	$3.5K	83,804	SEC↗
CHURCH KEVIN	Chief Scientific Officer	A Award	2023-01-04	2024-01-08	10,000	—	$0	82,668	SEC↗
Gengos Andrew	See Below	A Award	2023-01-04	2024-01-08	5,000	—	$0	85,012	SEC↗
MILESON GLENNA	Chief Financial Officer	P Buy	2022-12-28	2022-12-30	50,000	$2.85	$142.5K	159,930	SEC↗
Romano Kelly A	Director	P Buy	2022-12-02	2022-12-06	30,000	$3.29	$98.7K	38,315	SEC↗
CHURCH KEVIN	Executive VP, Research	A Award	2022-11-18	2023-01-23	657	$2.74	$1.8K	62,052	SEC↗
Litton Mark James	Chief Executive Officer	A Award	2022-11-18	2023-01-31	662	$2.74	$1.8K	129,217	SEC↗
MILESON GLENNA	Chief Financial Officer	A Award	2022-11-18	2022-12-30	763	$2.74	$2.1K	109,930	SEC↗
MOEBIUS HANS	Chief Medical Officer	P Buy	2022-11-15	2022-11-17	5,000	$3.29	$16.4K	65,836	SEC↗
CHURCH KEVIN	Executive VP, Research	M Exercise deriv	2022-10-28	2022-10-31	3,700	—	$0	6,410	SEC↗
CHURCH KEVIN	Executive VP, Research	M Exercise	2022-10-28	2022-10-31	3,700	$1.35	$5.0K	61,395	SEC↗
MOEBIUS HANS	Chief Medical Officer	M Exercise deriv	2022-10-13	2022-10-17	7,881	—	$0	7,882	SEC↗
MOEBIUS HANS	Chief Medical Officer	M Exercise	2022-10-13	2022-10-17	7,881	$1.35	$10.6K	60,836	SEC↗
EDELMAN JOSEPH	Director, 10% Owner	P Buy	2022-06-30	2022-07-01	1,101,362	$2.99	$3.29M	4,797,278	SEC↗
EDELMAN JOSEPH	Director, 10% Owner	P Buy	2022-06-29	2022-07-01	270,000	$2.99	$807.3K	3,695,916	SEC↗
MOEBIUS HANS	Chief Medical Officer	P Buy	2022-06-28	2022-06-30	10,000	$2.88	$28.8K	52,955	SEC↗
CHURCH KEVIN	Executive VP, Research	S Sale	2022-06-23	2022-06-24	2,614	$2.69	$7.0K	57,695	SEC↗
Lenington Rachel	Chief Operating Officer	S Sale	2022-06-23	2022-06-24	4,193	$2.69	$11.3K	5,807	SEC↗
Litton Mark James	Chief Executive Officer	S Sale	2022-06-23	2022-06-24	7,960	$2.69	$21.4K	128,555	SEC↗
MILESON GLENNA	Chief Financial Officer	S Sale	2022-06-23	2022-06-24	2,614	$2.69	$7.0K	109,167	SEC↗
Worthington Mark	General Counsel	S Sale	2022-06-23	2022-06-24	2,614	$2.69	$7.0K	19,097	SEC↗
CHURCH KEVIN	Executive VP, Research	A Award	2022-06-22	2022-06-24	10,000	—	$0	60,309	SEC↗
Lenington Rachel	Chief Operating Officer	A Award	2022-06-22	2022-06-24	10,000	—	$0	10,000	SEC↗
Litton Mark James	Chief Executive Officer	A Award	2022-06-22	2022-06-24	20,000	—	$0	136,515	SEC↗
MILESON GLENNA	Chief Financial Officer	A Award	2022-06-22	2022-06-24	10,000	—	$0	111,781	SEC↗
MOEBIUS HANS	Chief Medical Officer	A Award	2022-06-22	2022-06-24	10,000	—	$0	42,955	SEC↗
Worthington Mark	General Counsel	A Award	2022-06-22	2022-06-24	10,000	—	$0	21,711	SEC↗
CHURCH KEVIN	Executive VP, Research	M Exercise deriv	2022-06-08	2022-06-10	2,500	—	$0	10,110	SEC↗
CHURCH KEVIN	Executive VP, Research	M Exercise	2022-06-08	2022-06-10	2,500	$1.35	$3.4K	50,309	SEC↗
PERCEPTIVE LIFE SCIENCES MASTE	Director, 10% Owner	A Award deriv	2022-05-20	2022-05-27	13,871	—	$0	13,871	SEC↗
Panzara Michael A.	Director	A Award deriv	2022-05-20	2022-05-27	2,311	—	$0	2,311	SEC↗
JOHNSON JAMES A	Director	A Award deriv	2022-05-20	2022-05-27	13,871	—	$0	13,871	SEC↗
FLUKE JOHN M JR	Director	A Award deriv	2022-05-20	2022-05-27	13,871	—	$0	13,871	SEC↗
EDELMAN JOSEPH	Director	A Award deriv	2022-05-20	2022-05-27	13,871	—	$0	13,871	SEC↗
Kosacz Barbara	Director	A Award deriv	2022-05-20	2022-05-27	13,871	—	$0	13,871	SEC↗
Romano Kelly A	Director	A Award deriv	2022-05-20	2022-05-27	13,871	—	$0	13,871	SEC↗
PICKERING GRANT	Director	A Award deriv	2022-05-20	2022-05-27	3,467	—	$0	3,467	SEC↗
CHURCH KEVIN	Executive VP, Research	A Award	2022-05-18	2022-06-10	243	$7.06	$1.7K	47,809	SEC↗
Litton Mark James	Chief Executive Officer	A Award	2022-05-18	2022-06-24	757	$7.06	$5.3K	116,515	SEC↗
MILESON GLENNA	Chief Financial Officer	A Award	2022-05-18	2022-06-24	1,721	$7.06	$12.2K	101,781	SEC↗
MOEBIUS HANS	Chief Medical Officer	A Award	2022-05-18	2022-06-24	1,699	$7.06	$12.0K	32,955	SEC↗
Worthington Mark	General Counsel	A Award	2022-05-18	2022-06-24	3,396	$7.06	$24.0K	11,711	SEC↗
MILESON GLENNA	Chief Financial Officer	M Exercise deriv	2022-04-11	2022-04-12	3,000	—	$0	167,000	SEC↗
MILESON GLENNA	Chief Financial Officer	M Exercise	2022-04-11	2022-04-12	3,000	$10.64	$31.9K	100,060	SEC↗
Romano Kelly A	Director	P Buy	2022-03-31	2022-04-01	8,000	$13.11	$104.9K	8,315	SEC↗
Panzara Michael A.	Director	A Award deriv	2022-03-18	2022-03-21	27,742	—	$0	27,742	SEC↗
CHURCH KEVIN	Executive VP, Research	M Exercise deriv	2022-02-18	2022-02-18	3,152	—	$0	0	SEC↗
CHURCH KEVIN	Executive VP, Research	M Exercise	2022-02-18	2022-02-18	3,152	$1.19	$3.8K	47,566	SEC↗
PICKERING GRANT	Director	A Award deriv	2022-01-27	2022-01-31	27,742	—	$0	27,742	SEC↗
Litton Mark James	Chief Executive Officer	A Award deriv	2022-01-27	2022-01-31	400,000	—	$0	400,000	SEC↗
CHURCH KEVIN	Executive VP, Research	A Award deriv	2022-01-18	2022-01-20	100,000	—	$0	100,000	SEC↗
MOEBIUS HANS	Chief Medical Officer	A Award deriv	2022-01-18	2022-01-20	180,000	—	$0	180,000	SEC↗
Worthington Mark	General Counsel	A Award deriv	2022-01-18	2022-01-20	150,000	—	$0	150,000	SEC↗
MILESON GLENNA	Chief Financial Officer	A Award deriv	2022-01-18	2022-01-20	170,000	—	$0	170,000	SEC↗
Lenington Rachel	Chief Operating Officer	A Award deriv	2022-01-18	2022-01-20	180,000	—	$0	180,000	SEC↗
MILESON GLENNA	Chief Financial Officer	M Exercise deriv	2022-01-04	2022-01-06	6,305	—	$0	0	SEC↗
MILESON GLENNA	Chief Financial Officer	M Exercise	2022-01-04	2022-01-06	6,305	$1.35	$8.5K	97,060	SEC↗
MILESON GLENNA	Chief Financial Officer	A Award	2021-11-18	2022-01-06	931	$12.51	$11.6K	90,755	SEC↗
CHURCH KEVIN	Executive VP, Research	A Award	2021-11-18	2022-01-20	96	$12.51	$1.2K	44,414	SEC↗
MOEBIUS HANS	Chief Medical Officer	A Award	2021-11-18	2022-01-20	829	$12.51	$10.4K	31,256	SEC↗
Litton Mark James	Chief Executive Officer	A Award	2021-11-18	2022-01-31	885	$12.51	$11.1K	115,758	SEC↗
Lenington Rachel	Chief Operating Officer	A Award deriv	2021-11-03	2021-11-05	150,000	—	$0	150,000	SEC↗
Worthington Mark	General Counsel	A Award deriv	2021-11-03	2021-11-05	150,000	—	$0	150,000	SEC↗
Litton Mark James	Chief Operating Officer	M Exercise deriv	2021-08-17	2021-08-19	50,440	—	$0	100,880	SEC↗
Litton Mark James	Chief Operating Officer	M Exercise	2021-08-17	2021-08-19	50,440	$1.35	$68.1K	114,873	SEC↗
MOEBIUS HANS	Chief Medical Officer	M Exercise deriv	2021-07-21	2021-07-21	12,610	—	$0	0	SEC↗
MOEBIUS HANS	Chief Medical Officer	M Exercise deriv	2021-07-21	2021-07-21	15,762	—	$0	15,763	SEC↗
MOEBIUS HANS	Chief Medical Officer	M Exercise	2021-07-21	2021-07-21	15,762	$1.35	$21.3K	30,427	SEC↗
MOEBIUS HANS	Chief Medical Officer	M Exercise	2021-07-21	2021-07-21	12,610	$1.35	$17.0K	14,665	SEC↗
FLUKE JOHN M JR	Director	J Other	2021-06-15	2021-06-16	3,000	—	$0	3,731	SEC↗
FLUKE JOHN M JR	Director	J Other	2021-06-15	2021-06-16	1,000	—	$0	144,884	SEC↗
MILESON GLENNA	Chief Financial Officer	M Exercise deriv	2021-06-10	2021-06-10	6,305	—	$0	6,305	SEC↗
MILESON GLENNA	Chief Financial Officer	M Exercise	2021-06-10	2021-06-10	6,305	$1.35	$8.5K	89,824	SEC↗
CHURCH KEVIN	Vice President of Discovery	M Exercise deriv	2021-06-08	2021-06-09	3,152	—	$0	0	SEC↗
CHURCH KEVIN	Vice President of Discovery	M Exercise deriv	2021-06-08	2021-06-10	3,152	—	$0	0	SEC↗
CHURCH KEVIN	Vice President of Discovery	M Exercise	2021-06-08	2021-06-09	3,152	$1.04	$3.3K	44,133	SEC↗
CHURCH KEVIN	Vice President of Discovery	M Exercise	2021-06-08	2021-06-10	3,152	$1.04	$3.3K	44,318	SEC↗
EDELMAN JOSEPH	Director	A Award deriv	2021-05-28	2021-06-01	13,871	—	$0	13,871	SEC↗
JOHNSON JAMES A	Director	A Award deriv	2021-05-28	2021-06-01	13,871	—	$0	13,871	SEC↗
Yamada Tadataka	Director	A Award deriv	2021-05-28	2021-06-01	13,871	—	$0	13,871	SEC↗
FLUKE JOHN M JR	Director	A Award deriv	2021-05-28	2021-06-01	13,871	—	$0	13,871	SEC↗
PERCEPTIVE LIFE SCIENCES MASTE	Director	A Award deriv	2021-05-28	2021-06-01	13,871	—	$0	13,871	SEC↗
MOEBIUS HANS	Chief Medical Officer	A Award	2021-05-18	2021-07-21	2,055	$14.45	$29.7K	2,055	SEC↗
Litton Mark James	Chief Operating Officer	A Award	2021-05-18	2021-08-19	867	$14.45	$12.5K	64,433	SEC↗
CHURCH KEVIN	Vice President of Discovery	A Award	2021-05-18	2021-06-10	185	$14.45	$2.7K	41,166	SEC↗
MILESON GLENNA	Chief Financial Officer	A Award	2021-05-18	2021-06-10	1,554	$14.45	$22.5K	83,519	SEC↗
Kosacz Barbara	Director	A Award deriv	2021-03-04	2021-03-08	27,742	—	$0	27,742	SEC↗
CHURCH KEVIN	Vice President of Discovery	A Award deriv	2021-02-18	2021-02-22	20,000	—	$0	20,000	SEC↗
KAWAS LEEN	President & CEO	A Award deriv	2021-02-18	2021-02-22	231,000	—	$0	231,000	SEC↗
Litton Mark James	Chief Operating Officer	A Award deriv	2021-02-18	2021-02-22	85,000	—	$0	85,000	SEC↗
MILESON GLENNA	Chief Financial Officer	A Award deriv	2021-02-18	2021-02-22	73,500	—	$0	73,500	SEC↗
MOEBIUS HANS	Chief Medical Officer	A Award deriv	2021-02-18	2021-02-22	72,000	—	$0	72,000	SEC↗
FLUKE JOHN M JR	Director	M Exercise deriv	2021-02-03	2021-02-04	25,220	—	$0	0	SEC↗
FLUKE JOHN M JR	Director	M Exercise deriv	2021-02-03	2021-02-04	3,783	—	$0	0	SEC↗
FLUKE JOHN M JR	Director	M Exercise	2021-02-03	2021-02-04	3,783	$1.35	$5.1K	143,884	SEC↗
FLUKE JOHN M JR	Director	M Exercise	2021-02-03	2021-02-04	25,220	$1.19	$30.0K	140,101	SEC↗
EDELMAN JOSEPH	Director, 10% Owner	P Buy	2021-01-25	2021-01-27	311,111	$22.50	$7.00M	3,425,916	SEC↗
Romano Kelly A	Director	A Award deriv	2020-12-11	2020-12-14	27,742	—	$0	27,742	SEC↗
Litton Mark James	Chief Operating Officer	C Conversion deriv	2020-09-22	2020-09-22	6,563	—	$0	0	SEC↗
Litton Mark James	Chief Operating Officer	C Conversion deriv	2020-09-22	2020-09-22	13,126	—	$0	0	SEC↗
Litton Mark James	Chief Operating Officer	C Conversion deriv	2020-09-22	2020-09-22	6,563	—	$0	0	SEC↗
Litton Mark James	Chief Operating Officer	C Conversion deriv	2020-09-22	2020-09-22	6,563	—	$0	0	SEC↗
FLUKE JOHN M JR	Director	C Conversion deriv	2020-09-22	2020-09-22	51,831	—	$0	0	SEC↗
FLUKE JOHN M JR	Director	C Conversion deriv	2020-09-22	2020-09-22	6,731	—	$0	0	SEC↗
FLUKE JOHN M JR	Director	C Conversion deriv	2020-09-22	2020-09-22	12,610	—	$0	0	SEC↗
EDELMAN JOSEPH	Director, 10% Owner	C Conversion deriv	2020-09-22	2020-09-22	1,644,785	—	$0	0	SEC↗
PERCEPTIVE LIFE SCIENCES MASTE	10% Owner	C Conversion deriv	2020-09-22	2020-09-22	1,644,785	—	$0	0	SEC↗
Litton Mark James	Chief Operating Officer	C Conversion	2020-09-22	2020-09-22	6,563	—	$0	6,563	SEC↗
Litton Mark James	Chief Operating Officer	C Conversion	2020-09-22	2020-09-22	6,563	—	$0	6,563	SEC↗
Litton Mark James	Chief Operating Officer	C Conversion	2020-09-22	2020-09-22	13,126	—	$0	63,566	SEC↗
Litton Mark James	Chief Operating Officer	C Conversion	2020-09-22	2020-09-22	6,563	—	$0	6,563	SEC↗
FLUKE JOHN M JR	Director	C Conversion	2020-09-22	2020-09-22	51,831	—	$0	114,881	SEC↗
FLUKE JOHN M JR	Director	C Conversion	2020-09-22	2020-09-22	6,731	—	$0	6,731	SEC↗
FLUKE JOHN M JR	Director	C Conversion	2020-09-22	2020-09-22	12,610	—	$0	63,050	SEC↗
EDELMAN JOSEPH	Director, 10% Owner	P Buy	2020-09-22	2020-09-22	1,058,824	$17.00	$18.00M	3,114,805	SEC↗
EDELMAN JOSEPH	Director, 10% Owner	C Conversion	2020-09-22	2020-09-22	1,644,785	—	$0	2,055,981	SEC↗
PERCEPTIVE LIFE SCIENCES MASTE	10% Owner	P Buy	2020-09-22	2020-09-22	1,058,824	$17.00	$18.00M	3,114,805	SEC↗